Supplementary Figure S2 from Blocking the TCA Cycle in Cancer Cells Potentiates CD36+ T-cell–Mediated Antitumor Immunity by Suppressing ER Stress–Associated THBS2 Signaling
Year: 2025
Type: supplementary-materials
Abstract: CPI-613 does not yield noticeable side effect in MOC2 tumor-bearing C57BL/6 mice
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4410970934
